Meeting
2023 ASCO Annual Meeting
68Ga-FAPI-46 PET for cancer imaging: A prospective single-arm clinical trial.
Authors
Wolfgang P. Fendler
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany
Wolfgang P. Fendler , Timo Bartel , Kim M. Pabst , Rainer Hamacher , Nader Hirmas , Robert Seifert , Stefan Kasper , Michael Nader , Claudia Kesch , Bastian von Tresckow , Christoph Berliner , Sherko Kuemmel , Philipp Harter , Anke C. Reinacher-Schick , Celine Lugnier , Waldemar Uhl , Boris A. Hadaschik , Jens T. Siveke , Viktor Grünwald , Ken Herrmann
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Molecular Diagnostics and Imaging
Clinical Trial Registration Number
NCT05160051
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3064)
DOI
10.1200/JCO.2023.41.16_suppl.3064
Abstract #
3064
Poster Bd #
262
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA PET imaging for evaluation of recurrent or persistent prostate cancer after primary prostate radiation.
First Author: Richard Bennett IV
Poster
2023 ASCO Genitourinary Cancers Symposium
BPH-related false positive of 68Ga-PSMA PET/CT in the diagnosis of prostate cancer: The Achilles heel of biopsy-free radical prostatectomy?
First Author: Wei Tang
Poster
2022 ASCO Annual Meeting
Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer.
First Author: Natasha Hunter
First Author: Thomas A. Hope